Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells
- PMID: 2355006
Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells
Abstract
This report describes the structural characterization of the recombinant envelope glycoprotein (rgp120) of human immunodeficiency virus type 1 produced by expression in Chinese hamster ovary cells. Enzymatic cleavage of rgp120 and reversed-phase high performance liquid chromatography were used to confirm the primary structure of the protein, to assign intrachain disulfide bonds, and to characterize potential sites for N-glycosylation. All of the tryptic peptides identified were consistent with the primary structure predicted from the cDNA sequence. Tryptic mapping studies combined with treatment of isolated peptides with Staphylococcus aureus V8 protease or with peptide:N-glycosidase F followed by endoproteinase Asp-N permitted the assignment of all nine intrachain disulfide bonds of rgp120. The 24 potential sites for N-glycosylation were characterized by determining the susceptibilities of the attached carbohydrate structures to peptide:N-glycosidase F and to endo-beta-N-acetylglucosaminidase H. Tryptic mapping of enzymatically deglycosylated rgp120 was used in conjunction with Edman degradation and fast atom bombardment-mass spectrometry of individually treated peptides to determine which of these sites are glycosylated and what types of structures are present. The results indicate that all 24 sites of gp120 are utilized, including 13 that contain complex-type oligosaccharides as the predominant structures, and 11 that contain primarily high mannose-type and/or hybrid-type oligosaccharide structures.
Similar articles
-
Characterization of a soluble form of human CD4. Peptide analyses confirm the expected amino acid sequence, identify glycosylation sites and demonstrate the presence of three disulfide bonds.Eur J Biochem. 1990 Mar 10;188(2):291-300. doi: 10.1111/j.1432-1033.1990.tb15402.x. Eur J Biochem. 1990. PMID: 2318210
-
Site-specific N-glycosylation and oligosaccharide structures of recombinant HIV-1 gp120 derived from a baculovirus expression system.Biochemistry. 1993 Oct 19;32(41):11087-99. doi: 10.1021/bi00092a019. Biochemistry. 1993. PMID: 8218172
-
Carbohydrate structures of recombinant soluble human CD4 expressed in Chinese hamster ovary cells.Biochemistry. 1991 Mar 5;30(9):2395-406. doi: 10.1021/bi00223a015. Biochemistry. 1991. PMID: 2001369
-
Carbohydrate structures of human tissue plasminogen activator expressed in Chinese hamster ovary cells.J Biol Chem. 1989 Aug 25;264(24):14100-11. J Biol Chem. 1989. PMID: 2503511
-
[Structure and function of oligosaccharide chains of the envelope glycoprotein gp120 of human immunodeficiency virus type 1].Nihon Rinsho. 1992 Jun;50(6):1419-29. Nihon Rinsho. 1992. PMID: 1518160 Review. Japanese.
Cited by
-
Glycosylation of simian immunodeficiency virus influences immune-tissue targeting during primary infection, leading to immunodeficiency or viral control.J Virol. 2012 Sep;86(17):9323-36. doi: 10.1128/JVI.00948-12. Epub 2012 Jun 20. J Virol. 2012. PMID: 22718828 Free PMC article.
-
The griffithsin dimer is required for high-potency inhibition of HIV-1: evidence for manipulation of the structure of gp120 as part of the griffithsin dimer mechanism.Antimicrob Agents Chemother. 2013 Aug;57(8):3976-89. doi: 10.1128/AAC.00332-13. Epub 2013 Jun 10. Antimicrob Agents Chemother. 2013. PMID: 23752505 Free PMC article.
-
Nonrandom distribution of gp120 N-linked glycosylation sites important for infectivity of human immunodeficiency virus type 1.Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2213-7. doi: 10.1073/pnas.89.6.2213. Proc Natl Acad Sci U S A. 1992. PMID: 1549584 Free PMC article.
-
Envelope glycoprotein determinants of neutralization resistance in a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2) derived by passage in monkeys.J Virol. 2001 May;75(9):4208-18. doi: 10.1128/JVI.75.9.4208-4218.2001. J Virol. 2001. PMID: 11287570 Free PMC article.
-
Role of complex carbohydrates in human immunodeficiency virus type 1 infection and resistance to antibody neutralization.J Virol. 2010 Jun;84(11):5637-55. doi: 10.1128/JVI.00105-10. Epub 2010 Mar 24. J Virol. 2010. PMID: 20335257 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources